We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $143M invested in State Street SPDR S&P Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
37% more capital invested
Capital invested by funds: $105M → $143M (+$38.6M)
11% more funds holding
Funds holding: 72 → 80 (+8)
3.65% more ownership
Funds ownership: 47.58% → 51.23% (+3.7%)
42% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 26
Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
15
Reduced
26
Closed
5
Calls
$2.29M
Puts
–
Net Calls
+$2.29M
Net Calls Change
+$85K
Top Buyers
| 1 |
FMI
Factory Mutual Insurance
Waltham,
Massachusetts
|
+$10M |
| 2 |
Goldman Sachs
New York
|
+$5.73M |
| 3 |
Morgan Stanley
New York
|
+$3.97M |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$1.43M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$1.32M |
Top Sellers
| 1 |
CI
CX Institutional
Auburn,
Indiana
|
-$1.69M |
| 2 |
JP Morgan Chase
New York
|
-$1.38M |
| 3 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$1.36M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.06M |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$868K |
